Liranaftate

Research use only, not for human use.

Liranaftate is a squalene epoxidase inhibitor with anti-fungicidal activities.

Liranaftate is a squalene epoxidase inhibitor with anti-fungicidal activities.(In Vitro):Liranaftate showed excellent fungistatic activity against the conidia of T. rubrum. For each of these agents, the MIC after 14 days of contact was 0.009 g/ml. The liranaftate-induced decrease in the MCC occurred from 9 days onwards; MCC at 14 days was 0.039 g/ml . In time-kill studies, liranaftate showed the greatest decrease to a below detection limit in viable counts of T rubrum. The degree of killing of the strain by amorolfine was not greater than that seen by liranaftate, and little reduction of the viable counts by luliconazole and ketoconazole was observed irrespective of concentrations of the agents .

Liranaftate showed excellent fungistatic activity against the conidia of T. rubrum. For each of these agents, the MIC after 14 days of contact was 0.009 g/ml. The liranaftate-induced decrease in the MCC occurred from 9 days onwards; MCC at 14 days was 0.039 g/ml . In time-kill studies, liranaftate showed the greatest decrease to a below detection limit in viable counts of T rubrum. The degree of killing of the strain by amorolfine was not greater than that seen by liranaftate, and little reduction of the viable counts by luliconazole and ketoconazole was observed irrespective of concentrations of the agents .

——

Liranaftate | M-732 | Piritetrate

Microbiology/Virology

Antifungal

squalene epoxidase

Infection

——

88678-31-3

328.43

C18H20N2O2S

>98% (HPLC)

DMSO: >5mM

O=C(OC1=CC=C2CCCCC2=C1)N(SC)C3=NC(OC)=CC=C3

O-(5,6,7,8,-Tetrahydro-2-naphthyl) 6-methoxy-N-methylthio-2-pyridinecarbamate

(-20℃)

With Ice Pack

≥ 2 years